The report reveals critical alternatives to traditional WARF licensing, such as moving research overseas, establishing collaborations with companies that are existing WARF licensees, structuring creative negotiating alternatives, developing products for other species – and other breakthrough strategies.
BioInformant's report also offers historical and future growth projections for the embryonic stem cell product market, competitive analysis of existing providers, and detailed assessment of creative strategies for developing high-demand products. This insight is possible, because BioInformant has been the global leader in stem cell industry data since 2006 and is the only producer of market intelligence data specific for the stem cell sector.
Free samples from the full document are available at: http://www.giiresearch.com/report/biof242923-opportunities-human-embryonic-stem-cell-product.html
Stem Cell Research Products - Opportunities, Tools, and Technologies
Staying ahead of a hungry and fast moving pack of competitors requires the very best market insights, and BioInformant also offers a sophisticated market intelligence report for the stem cell research supply market.
Whether you already supply stem cell research products or you wish to expand your product line, you'll know just how essential and lucrative this market is. We know you want to make effective product development decisions, to sell more effectively to scientists, to generate improved revenues and take market share from your competition.
Stem Cell Research Products - Opportunities, Tools, and Technologies - published in May 2012 - shows you how to do just that. Helping you understan
'/>"/>
| SOURCE Global Information, Inc. Copyright©2010 PR Newswire. All rights reserved |